Jing Jia

Dr. Jing Jia


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 November 2024 in Environmental Pollution
Verified
Journal Article
Closed access
HYHao Yin
Hao Yin
YZYaoyao Zheng
Yaoyao Zheng
MCMenghan Chen
Menghan Chen
MDMing Ding
Ming Ding
LZLin Zhang
Lin Zhang
XLXiaoqian Liu
Xiaoqian Liu

29 May 2026 in Cell Death & Disease
Verified
Journal Article
Open access
YLYunqian Li
Yunqian Li
HWHe Wen
He Wen
HZHan Zheng
Han Zheng
YZYunyue Zhen
Yunyue Zhen
JJJing Jia
Jing Jia
ZLZhengjun Li
Zhengjun Li
Cutaneous squamous cell carcinoma (cSCC) is a common and aggressive skin cancer, with treatment options for advanced stages often limited by chemoresistance. Here, we observe a positive correlation between PHF20 expression and the malignancy and tumor grade of cSCC. Functional studies suggest that PHF20 promotes oncogenic phenotypes, including proliferation, invasion, and epithelial-mesenchymal transition. Notably, PHF20 depletion appears to sensitize cSCC cells to chemotherapeutic agents. Mechanistically, we show that PHF20 interacts with and promotes the ubiquitin-mediated degradation of GAS7. This downregulation of GAS7 is associated with nuclear F-actin assembly, a process that has been implicated in DNA damage repair (DDR). Consequently, PHF20 loss stabilizes GAS7, enhances nuclear F-actin assembly, and is accompanied by increased DNA damage accumulation. These in vitro findings were corroborated in vivo, where PHF20 knockdown suppressed tumor growth and increased DNA damage. Together, PHF20 may contribute to the regulation of DDR and chemotherapeutic response, highlighting its potential as a therapeutic target in poorly differentiated cSCC.